9120 Second-line amrubicin vs topotecan in extensive-disease small cell lung cancer (ED-SCLC) sensitive to first-line platinum-based chemotherapy: updated results of a randomized phase 2 trial

R. Jotte; P.R. Conkling; C. Reynolds; C. Shah; M. Galsky; L. Klein; J.F. Fitzgibbons; R. McNally; J.W. Oliver; M. Renschler

doi:10.1016/s1359-6349(09)71833-6

9120 Second-line amrubicin vs topotecan in extensive-disease small cell lung cancer (ED-SCLC) sensitive to first-line platinum-based chemotherapy: updated results of a randomized phase 2 trial

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)71833-6 ◽

2009 ◽

Vol 7 (2) ◽

pp. 540-541

Author(s):

R. Jotte ◽

P.R. Conkling ◽

C. Reynolds ◽

C. Shah ◽

M. Galsky ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell ◽

Second Line ◽

Phase 2 ◽

Small Cell Lung ◽

First Line ◽

Extensive Disease ◽

Phase 2 Trial ◽

Platinum Based Chemotherapy ◽

Randomized Phase 2

Download Full-text

9121 Amrubicin monotherapy in patients with extensive disease small cell lung cancer (ED-SCLC) refractory to first-line platinum-based chemotherapy: final results of a phase 2 trial

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)71834-8 ◽

2009 ◽

Vol 7 (2) ◽

pp. 541

Author(s):

D.S. Ettinger ◽

R. Jotte ◽

P. Lorigan ◽

V. Gupta ◽

L. Garbo ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

First Line ◽

Extensive Disease ◽

Phase 2 Trial ◽

Platinum Based Chemotherapy

Download Full-text

Disrupt: A Randomized Phase 2 Trial of Ombrabulin (AVE8062) Combined with a Taxane-Platinum Regimen in the First-Line Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC)

Annals of Oncology ◽

10.1016/s0923-7534(20)33843-6 ◽

2012 ◽

Vol 23 ◽

pp. ix410

Author(s):

J. von Pawel ◽

V. Gorbounova ◽

M. Reck ◽

D. Kowalski ◽

A. Allard ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Phase 2 ◽

Small Cell Lung ◽

First Line ◽

Phase 2 Trial ◽

Randomized Phase 2 ◽

First Line Treatment

Download Full-text

DISRUPT: A randomized phase 2 trial of ombrabulin (AVE8062) combined with a taxane-platinum regimen in the first-line treatment of metastatic non-small cell lung cancer (NSCLC)

Pneumologie ◽

10.1055/s-0033-1334708 ◽

2013 ◽

Vol 67 (S 01) ◽

Author(s):

J von Pawel ◽

V Gorbounova ◽

M Reck ◽

DM Kowalski ◽

A Allard ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Phase 2 ◽

Small Cell Lung ◽

First Line ◽

Phase 2 Trial ◽

Randomized Phase 2 ◽

First Line Treatment

Download Full-text

Randomized phase 2 study comparing irinotecan versus amrubicin as maintenance therapy after first‐line induction therapy for extensive disease small cell lung cancer ( HOT1401 / NJLCG1401 )

Thoracic Cancer ◽

10.1111/1759-7714.14048 ◽

2021 ◽

Author(s):

Hisashi Tanaka ◽

Yukihiro Hasegawa ◽

Yuka Fujita ◽

Atsushi Nakamura ◽

Eiki Kikuchi ◽

...

Keyword(s):

Lung Cancer ◽

Maintenance Therapy ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

First Line ◽

Extensive Disease ◽

Phase 2 Study ◽

Randomized Phase 2

Download Full-text

Durvalumab, Tremelimumab Alone or in Combination With Low-Dose or Hypofractionated Targeted Radiotherapy in Metastatic Non-Small Cell Lung Cancer Refractory to Prior PD-1 Therapy: A Multicentre, Open-Label, Randomized, Phase 2 Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3922682 ◽

2021 ◽

Author(s):

Jonathan D. Schoenfeld ◽

Anita Giobbie-Hurder ◽

Srinika Ranasinghe ◽

Katrina Z. Kao ◽

Ana Lako ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Low Dose ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Open Label ◽

Targeted Radiotherapy ◽

Phase 2 Trial ◽

Randomized Phase 2

Download Full-text

Final Results of a Randomized Phase 2 Study Comparing Carboplatin Plus Irinotecan (Ci) Versus Carboplatin Plus Amrubicin (Ca) for Extensive Disease Small-Cell Lung Cancer: Njlcg0901

Annals of Oncology ◽

10.1093/annonc/mdu355.14 ◽

2014 ◽

Vol 25 ◽

pp. iv515

Author(s):

Y. Tsukita ◽

N. Morikawa ◽

S. Sugawara ◽

M. Maemondo ◽

T. Harada ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Extensive Disease ◽

Phase 2 Study ◽

Randomized Phase 2

Download Full-text

P1.13-36 Randomized Phase 2 Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2018.08.893 ◽

2018 ◽

Vol 13 (10) ◽

pp. S596

Author(s):

L. Sequist ◽

J. Gray ◽

W. Harb ◽

R. Doebele ◽

M. Modiano ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase 2 ◽

Wild Type ◽

Small Cell Lung ◽

Phase 2 Trial ◽

Randomized Phase 2

Download Full-text

Abstract 4606: Randomized phase 2 study of efatutazone in combination with carboplatin and paclitaxel as first-line therapy for metastatic non-small cell lung cancer (NSCLC)

10.1158/1538-7445.am2012-4606 ◽

2012 ◽

Author(s):

Alice T. Shaw ◽

Doru Ghizdavescu ◽

Minish Jain ◽

Constantin Volovat ◽

Deepa Subramaniam ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Phase 2 Study ◽

Randomized Phase 2

Download Full-text

Functional Lung Avoidance Radiation Therapy for Stage III Non-Small Cell Lung Cancer: A Double-Blind Randomized Phase 2 Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2015.07.213 ◽

2015 ◽

Vol 93 (3) ◽

pp. S89

Author(s):

B. Yaremko ◽

D.A. Palma ◽

G. Parraga ◽

D. Capaldi ◽

K. Sheikh ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Double Blind ◽

Phase 2 Trial ◽

Randomized Phase 2

Download Full-text

A randomized phase 2 study of abemaciclib versus docetaxel in patients with stage IV squamous non-small cell lung cancer (sqNSCLC) previously treated with platinum-based chemotherapy.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.9059 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 9059-9059

Author(s):

Giorgio V. Scagliotti ◽

Igor Bondarenko ◽

Tudor-Eliade Ciuleanu ◽

Maciej Bryl ◽

Andrea Fülöp ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Stage Iv ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Platinum Based Chemotherapy ◽

Phase 2 Study ◽

Previously Treated ◽

Randomized Phase 2

Download Full-text